Small interfering RNA for cancer treatment: overcoming hurdles in delivery

In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. Th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Pharm Sin B
Auteurs principaux: Charbe, Nitin Bharat, Amnerkar, Nikhil D., Ramesh, B., Tambuwala, Murtaza M., Bakshi, Hamid A., Aljabali, Alaa A.A., Khadse, Saurabh C., Satheeshkumar, Rajendran, Satija, Saurabh, Metha, Meenu, Chellappan, Dinesh Kumar, Shrivastava, Garima, Gupta, Gaurav, Negi, Poonam, Dua, Kamal, Zacconi, Flavia C.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714980/
https://ncbi.nlm.nih.gov/pubmed/33304780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.10.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires